Complete financial analysis of Vicarious Surgical Inc. (RBOT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vicarious Surgical Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Energoaparatura SA (ENP.WA) Income Statement Analysis – Financial Results
- Robex Resources Inc. (RBX.V) Income Statement Analysis – Financial Results
- Packaging Corporation of America (0KEZ.L) Income Statement Analysis – Financial Results
- Phoenix Media Investment (Holdings) Limited (PXSTF) Income Statement Analysis – Financial Results
- The Williams Companies, Inc. (WMB) Income Statement Analysis – Financial Results
Vicarious Surgical Inc. (RBOT)
About Vicarious Surgical Inc.
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.85M | 1.94M | 316.00K | 0.00 | 0.00 |
| Gross Profit | -1.85M | -1.94M | -316.00K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 47.58M | 43.90M | 22.10M | 9.80M | 7.48M |
| General & Administrative | 26.86M | 29.72M | 13.50M | 2.33M | 2.05M |
| Selling & Marketing | 6.23M | 6.46M | 2.98M | 861.00K | 250.00K |
| SG&A | 33.09M | 36.18M | 16.47M | 3.19M | 2.30M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 80.67M | 80.08M | 38.57M | 12.99M | 9.78M |
| Cost & Expenses | 80.67M | 80.08M | 38.57M | 12.99M | 9.78M |
| Interest Income | 4.43M | 1.44M | 20.00K | 113.00K | 469.00 |
| Interest Expense | 25.00K | 200.00K | 89.00K | 3.00K | 0.00 |
| Depreciation & Amortization | 1.85M | 1.94M | 316.00K | 157.00K | 104.00K |
| EBITDA | -69.19M | 7.30M | -34.80M | -161.18K | -9.68M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -80.67M | -80.08M | -38.57M | -12.99M | -9.78M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 9.60M | 85.24M | 3.02M | 110.00K | 469.00K |
| Income Before Tax | -71.07M | 5.16M | -7.27M | -12.88M | -9.31M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -84.00M | -227.00K | 3.00K | -67.86K |
| Net Income | -71.07M | 89.16M | -7.04M | -12.88M | -9.31M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -14.70 | 20.77 | -2.19 | -4.91 | -1.70 |
| EPS Diluted | -14.60 | 20.99 | -2.19 | -4.91 | -1.70 |
| Weighted Avg Shares Out | 4.83M | 4.29M | 3.22M | 2.62M | 5.47M |
| Weighted Avg Shares Out (Dil) | 4.87M | 4.25M | 3.22M | 2.62M | 5.47M |
Vicarious Surgical to Report Third Quarter 2022 Financial Results on November 7, 2022
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the third quarter...
Vicarious Surgical Announces Changes to Board of Directors
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the resignation of technology-focused venture capitalists Dror Berman and Samir Kaul from the...
Vicarious Surgical Announces Upcoming Beta 2 Demonstration Day
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that it will host a Demonstration Day of its Beta 2 surgical robot...
The 7 Best Bargain Stocks to Buy Now
Given the unique circumstances associated with the Covid-19 pandemic, investors may want to take a step back from the crowd and consider the best bargain stocks to buy now. To be sure, several equity-based opportunities printed much red ink this...
Vicarious Surgical to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will present...
Vicarious Surgical to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will present...
Vicarious Surgical Inc. (RBOT) CEO Adam Sachs on Q2 2022 Results - Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Kaitlyn Brosco - Director, Investor Relations Adam Sachs - Chief Executive Officer Bill Kelly - Chief Financial Officer Conference Call Participants Matt...
Vicarious Surgical Reports Second Quarter 2022 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for...
Vicarious Surgical Reports Second Quarter 2022 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for...
Source: https://incomestatements.info
Category: Stock Reports